These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 43384)

  • 1. Plasma levels and beta-blocking effect of alpha-hydroxymetoprolol--metabolite of metoprolol--in the dog.
    Regårdh CG; Ek L; Hoffmann KJ
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):471-9. PubMed ID: 43384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
    Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
    Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
    Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
    Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM; Singh BN; Ambler PK; Dorrington R
    Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective and non-selective beta-blockade in renin release.
    Lammintausta R; Syvälahti E; Iisalo E; Kanto J; Mäntylä R
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):489-96. PubMed ID: 202141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction.
    Everts B; Karlson BW; Herlitz J; Abdon NJ; Hedner T
    Eur J Clin Pharmacol; 1997; 53(1):23-31. PubMed ID: 9349926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
    Bengtsson C; Johnsson G; Regårdh CG
    Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
    Quaterman CP; Kendall MJ; Welling PG
    Eur J Clin Pharmacol; 1979 Mar; 15(2):97-103. PubMed ID: 436924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective determination of metoprolol and its metabolite α-hydroxymetoprolol in plasma by LC-MS/MS: application to pharmacokinetics during pregnancy.
    Antunes Nde J; Cavalli RC; Marques MP; Lanchote VL
    Chirality; 2013 Jan; 25(1):1-7. PubMed ID: 23097090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?
    Parker G; Ene MD; Daneshmend TK; Roberts CJ
    J Clin Pharmacol; 1984; 24(11-12):493-9. PubMed ID: 6150945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and concentration--effect relationships of bevantolol (CI-775) in normal volunteers.
    McNeil JJ; Drummer OH; Anderson AI; Louis WJ
    J Cardiovasc Pharmacol; 1986; 8(6):1201-7. PubMed ID: 2434747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis.
    Syvälahti E; Lammintausta R; Iisalo E; Kanto J
    Ann Clin Res; 1977 Oct; 9(5):292-5. PubMed ID: 616215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies.
    McGourty JC; Silas JH; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 Dec; 20(6):555-66. PubMed ID: 2868742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test].
    Chaignon M; Lucsko M; Aubert P; Guédon J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):963-9. PubMed ID: 6128964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic metabolism of metoprolol: clinical studies.
    Silas JH; McGourty JC; Lennard MS; Tucker GT; Woods HF
    Eur J Clin Pharmacol; 1985; 28 Suppl():85-8. PubMed ID: 4054194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.